Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

Routine abdominal CTs offer insight into cardiovascular risk
During this year's RSNA meeting, providers were especially interested in how AI applications could enhance opportunistic screening capabilities.
Screening efforts have helped avert millions of cancer-related deaths in recent decades
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
What breast density status can tell us about cardiovascular risk
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
FDA clears AI tool that flags signs of heart disease in chest CT scans
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Patients without PCPs struggle to access lung cancer screening, despite eligibility
It is estimated that up to one-third of the U.S. population does not have a primary care provider.

The Nanox ARC cold-cathode, tomosythesis 3D X-ray system is currently pending FDA clearance. If cleared, it would be the first device of its kind to offer cold-cathode X-ray tube technology and the ability to slice through the anatomy in images similar to CT scans aid diagnosis. The new type of tube also could greatly reduce the size and weight of X-ray systems. The vendor sees this system as key to its larger plan to address health disparities and access to imaging world-wide. #Nanox

Can cold-cathode X-ray combined with teleradiology and AI eliminate health disparities?

The Israeli vendor Nanox says it has a vision for the future of healthcare. It seeks to address health disparities and access challenges with a new business model and innovative package of technologies. Hurdles loom, but opportunities abound.

November 17, 2022

Personalized breast cancer risk assessment could reduce overdiagnosis

Personalized breast cancer screening programs could help women better understand their personal cancer risks and guide providers in recommending mammographic assessments based on these risks.

November 16, 2022

Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients.

November 14, 2022

Why some women tend to overestimate their breast cancer risks

For women with dense breasts, it can be particularly challenging to differentiate between actual and perceived breast cancer risks.

November 8, 2022

What factors influence low follow-up adherence after a positive LDCT cancer screening?

Experts are calling for strategies to improve follow-up adherence among individuals who have positive lung cancer screenings after a new analysis revealed low rates of compliance.

November 3, 2022

Advances in computed tomography scanner (CT) technology include photon-counting (Siemens image left) and faster, higher slice CT systems with integrated AI. Right image is GE Healthcare's Revolution on display at SCCT 2022. Trends in CT imaging by Signify Research.

VIDEO: CT imaging market trends and advances overview by Signify Research

Bhvita Jani, research manager, Signify Research, explains key trends and technology advances in the computed tomography (CT) market.

November 1, 2022

The FDA tracks mammography systems and the number of exams performed in the U.S. through its Mammography Quality Standards Act (MQSA) program. This is an example of the GE Senobright HD imaging system.

Is contrast-enhanced mammography suitable for women with breast implants?

A new paper highlights several studies supporting the use of screening mammography for women with breast implants, as well as additional considerations that need to be made for these patients.

October 31, 2022

More than 6,000 mammograms reviewed after radiology group misses dozens of cancers

Cancer was identified in an additional 25 women, all of whom required either surgery, chemotherapy, radiation or a mastectomy.

October 26, 2022

Screening

Routine abdominal CTs offer insight into cardiovascular risk

Screening efforts have helped avert millions of cancer-related deaths in recent decades

What breast density status can tell us about cardiovascular risk

FDA clears AI tool that flags signs of heart disease in chest CT scans

Patients without PCPs struggle to access lung cancer screening, despite eligibility